Gary E. Gilbert, MD VA Boston Healthcare System, Harvard Medical School Boston, MA Platelet Phosphatidylserine Exposure, Survival and Blood Coagulation in Mice Lacking TMEM16F
Gary Gilbert.... I'm actually a bit surprised at this exposure into the VA Boston
----------------------------
Gary Gilbert
Principal Investigator at Research in blood coagulation, emphasizing membrane interface
Greater Boston Area Research
Current VA Boston Healthcare System, Harvard University, Research in blood coagulation, emphasizing membrane interface
Education Tufts University
286 connections
Experience
Chief, Hematology and Oncology VA Boston Healthcare System 2015 – Present (less than a year)VA Boston Healthcare System
Associate Prof of Medicine Harvard University 2011 – Present (4 years)
Principal Investigator Research in blood coagulation, emphasizing membrane interface September 1989 – Present (26 years 3 months)VA Boston Healthcare System
My laboratory focuses on coagulation factor VIII and lactadherin a.k.a. mfg-e8. We are particularly interested in the manner in which chemical and physical changes of the membrane regulate coagulation activity of the blood .. .. .. https://www.linkedin.com/pub/gary-gilbert/72/440/652
Nagata is to Phosphatidylserine as Dmitry Gabrilovich is to MDSC's...and WHO knows, maybe many feared that Peregrine interfearedon many other Big Pharmas legacy.
Nagata is still at it and all the talk about PS exposure will all lead to PS Targeting
Cell Death Gordon Research Conference
New Concepts in Cell Death Research: From Basic Mechanisms to Clinical Opportunities
Dates July 3-8, 2016 Location PGA Catalunya Business and Convention Centre Girona, Spain